Home
Conditions
Pertussis

Clinical trial condition

Pertussis

Explore clinical trials studying Pertussis. Study availability and eligibility vary by location and protocol.

154 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Pertussis trial results

Completed

Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand

NCT02408926

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +6 more
Locations: Chulalongkorn University Bangkok, Thailand

View Trial Details

Completed

Maternal Tdap Immunization in Guatemala

NCT02301702

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +6 more
Locations: Universidad del Valle de Guatemala Guatemala City, Guatemala

View Trial Details

Completed

2-year Follow-up After a Single Dose Acellular Pertussis Vaccination

NCT04113655

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +6 more
Locations: Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi, Bangkok, Thailand

Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

View Trial Details

Completed

3-year Follow-up After a Single Dose Acellular Pertussis Vaccination

NCT04102137

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +6 more
Locations: Vaccine Trial Centre, Faculty of Tropical Medicine, Mhahidol University, 420/6 Ratchawithi Road, Ratchathewi, Bangkok, Thailand

View Trial Details

Completed

A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia

NCT02858440

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +25 more
Locations: GSK Investigational Site Barnaul, Russia

GSK Investigational Site Murmansk, Russia

GSK Investigational Site Saint Petersburg, Russia

GSK Investigational Site Tomsk, Russia

View Trial Details

Completed

A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults

NCT03208101

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Korea University Guro Hospital Seoul, South Korea

View Trial Details

Completed

Pertussis Infection in Adolescents and Adults With Prolonged Cough

NCT01597687

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +6 more
Locations: GSK Investigational Site Kuala Lumpur, Malaysia

GSK Investigational Site Seremban, Malaysia

GSK Investigational Site Taichung, Taiwan

GSK Investigational Site Taoyuan, Taiwan

View Trial Details

Completed

The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks

NCT03931239

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +25 more
Locations: Hung Yen, Kim Dong Hung Yen, Vietnam

View Trial Details

Completed

Pertussis and Meningitis C Concomitant Vaccination in Adolescents

NCT02526394

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +11 more
Locations: Gloucestershire primary care Gloucestershire, United Kingdom

Hertfordshire primary care Hertfordshire, United Kingdom

View Trial Details

Completed

Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine

NCT00258882

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +9 more
Locations: Oakland, California, United States

Aurora, Colorado, United States

Portland, Oregon, United States

View Trial Details

Pertussis

Pertussis trial results

Related conditions